• Citer

When can chemotherapy be omitted and how does menopausal status matter?: Risk-adapted strategy in HR+/HER2 negative early breast cancer Session

par Sotiriou, Christos
Référence ESMO Asia Congress (December 2, 2022: Singapore)
Publication Non publié, 2022-12-02

Communication à un colloque

• Détails

Titre:	When can chemotherapy be omitted and how does menopausal status matter?: Risk-adapted strategy in HR+/HER2 negative early breast cancer Session
Auteur:	Sotiriou, Christos
Informations sur la publication:	ESMO Asia Congress (December 2, 2022: Singapore)
Statut de publication:	Non publié, 2022-12-02
Sujet CREF:	Cancérologie
Langue:	Anglais